First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...
An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...
Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, today announces the appointment of Francis Van Parys as Chief Executive ...
The OSHWC Code, 2020 and Social Security Code enhance worker protection in pharma through risk management, medical ...
Avatar: Fire & Ash stars Sam Worthington and Stephen Lang talked to us about how their characters have changed throughout the ...
Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis" report has been added to ResearchAndMarkets.com's offering. The ...
Australian animal-free casein maker Eden Brew has filed the country's first regulatory application for a precision-fermented ...
DNA nanostructures are exciting new biomedical tools with myriad potential in treatment, diagnosis and disease prevention.
High-resolution imaging has revealed the internal layout of chromatin condensates, showing how DNA fibers fold and interact ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback